Bullous pemphigoid: Interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation

Cytokine

Volumn 13, Issue 1, 2001, Pages 32-38

  Engineer, Leela ^a   Bhol, Kailash ^a   Kumari, Suman ^a   Razzaque Ahmed, A ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Bullous pemphigoid (BP); Eosinophils; Immunoglobulin E (IgE); Interleukin 5 (IL 5); Intravenous immunoglobulin (IVIg)

Indexed keywords

AUTOANTIBODY; BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 5; MEMBRANE PROTEIN;

ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BASEMENT MEMBRANE; BLISTER; CELL FUNCTION; CELL INFILTRATION; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; HEMIDESMOSOME; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NONHUMAN; PEMPHIGOID; PRIORITY JOURNAL; REMISSION; SKIN DEFECT;

BOVINAE;

EID: 0035819242     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0791     Document Type: Article

References (55)

1. Bullous pemphigoid
2. The blistering diseases
3. Cellular events leading to blister formation in bullous pemphigoid
4. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins
5. Ultrastructural aspects of infiltrated eosinophils in bullous pemphigoid
6. Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid
7. Bullous pemphigoid: Cytotoxic eosinophil degranulation and release of eosinophil major basic protein
8. Bullous pemphigoid: A cause of peripheral blood eosinophilia
9. Identification and partial characterization of pemphigoid antigen extracted from normal human skin
10. A 230-kD basic protein is the major bullous pemphigoid antigen
11. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting
12. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus
13. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies
14. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid
15. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)
16. Molecular events mediating T cell activation
17. Interleukin-5 synthesis by eosinophils: Association with granules and immunoglobulin dependent secretion
18. Interleukin-4, -5, -6 and tumor necrosis factor-alpha in normal and asthmatic airways. Evidence for the human mast cells as a source of these cytokines
19. The biological role of interleukin-5
20. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
21. Apoptosis in human eosinophils: Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5
22. Recombinant human interleukin 5 is a selective eosinophil chemoattractant
23. Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 α chain knock-out mice infected with Angiostrongylus cantonensis
24. IL-4 and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice
25. The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice
26. Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig)G1 and IgE
27. Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation
28. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms and airway methacholine responsiveness to asthma
29. Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome
30. Th2-like cytokine activity in dermatitis herpetiformis
31. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis
32. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid
33. Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid
34. IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: Correlations with eosinophil cationic protein, RANTES, IgE and disease severity
35. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: Relationships with disease intensity
36. Bullous pemphigoid, an ultrastructural study of the inflammatory response: Eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient
37. The biology of interleukin-5 and its receptor
38. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5
39. Expression cloning of the human IL-3 receptor cDNA reveals beta subunit for the human IL-3 and GM-CSF receptors
40. Cytokine receptors and signal transduction
41. Mechanism of lesion production in pemphigus and pemphigoid
42. Intravenous immuno globulin affects cytokine production in T lymphocytes and monocytes/macrophages
43. Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans
44. IgE and its related phenomenon in bullous pemphigoid
45. Antibody feedback suppression: Towards a unifying concept?
46. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE
47. The immune complex: Possible ways of regulating the antibody response
48. Transforming growth factor-β abrogates effects of hematopoietins on eosinophils and induced their apoptosis
49. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells
50. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10
51. Preliminary serological studies comparing immunofluorescence assay with radioimmunoassay
52. Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2
53. Bovine gingival lysate: A novel substrate for rapid diagnosis of autoimmune vesiculo-bullous diseases
54. The epitopes on bovine pemphigus foliaceus antigen are calcium dependent and located on peptide backbone of this glycoprotein
55. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedures and some applications